http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
안병민 ( Byung Min Ahn ) 대한소화기학회 2004 대한소화기학회지 Vol.44 No.3
Recently the use of herbal preparations as remedies for various medical conditions, has been rapidly increasing in Korea. In our previous study, 38.9% of patients with chronic liver disease were found to use some sorts of herbal preparations. They believe
광범위한 간문맥전이와 세동전이로 인해 간손상이 초래된 위암 - 비전형적인 방사선학적 소견과 병리조직소견
안병민(Byung Min Ahn),이봉수(Bong Soo Lee),송하헌(Ha Hyn Song),이혜경(Hye Kyung Lee),박찬욱(Chan Wook Park),김현(Hyun Kim) 대한소화기학회 1997 대한소화기학회지 Vol.30 No.6
In contrast to the primary hepatocellular carcinoma, tumor thrombosis of the portal vein is rarely found in metastatic liver cancer which is frequently found in the patients with primary cancers of organs that has portal venous drainage. We recently experienced a case of hepatic metastasis of gastric carcinoma showing unusual radiological findings in a 67-year-old woman. She complained of abdominal bloating during the second phase of combined chemotherapy. Four months ago she had received pylorus preserving gastrectomy for advanced gastric cancer. The liver CT showed raiher well marginated, geographic low attenuations distrubuted along periphery of liver and thrombosis of the main portal vein. After infusion of contrast media, the major part of peripheral low attenuation became isodense to the central portion of liver. Ultrasound guided multifocal biopses revealed massive portal venous tumor thrombosis and trans-sinusoidal metastasis of gastric carcinoma which was more severe in the areas of peripheral low echogenicity where hepatic necrosis and fibrosis were observed. In conclusion, geographic attenuation difference in the liver on cross sectional images can be induced by massive portal venous thrombosis and following hepatic injury in liver metastasis from gastric carcinoma. (Korean J Gastroenterol 1997; 30:831-836)
원발성 간암 환자에 대한 경도관간동맥화학색전술과 병용한 전신적 FAM 화학요법의 치료 효과 - 자연경과군 및 전신적 FAM 화학요법군과의 비교 -
안병민(Byung Min Ahn),김부성(Boo Sung Kim),정규원(Kyu Won Chung),선희식(Hee Sik Sun),양진모(Jin Mo Yang),양시영(Si Young Yang),이상헌(Sang Heon Lee),최명규(Myung Gyu Choi),최상욱(Sang Wook Choi),백남종(Nam Jong Baeg),심규식(Kyu Sik S 대한내과학회 1991 대한내과학회지 Vol.41 No.1
Hepatocellular carcinoma (HCC) is considered to be a highly malignant tumor with a poor prognosis. It is usually not resectable and there is no other definite treatment. Transcatheter arterial chemoembolization (TAE), now become one of the established treatments for hepatocellular carcinoma. We compared the therapeutic effects of TAE with systemic FAM chemotherapy with those of conservative treatment and systemic FAM chemotherapy alone in patients with large primary HCC during the last 3 years, retrospectively, in relation to prognostic factors, response rate, and survival time. In a total of 71 patients with large primary HCC and clinical status of Child grading A or B, 25 patients wen treated conservatively (Group A), 21 patients with systemic FAM chemotherapy alone (Group B), and 28 patients with TAE combined with systemic FAM chemotherapy (Group C). The results were as follows: 1) There was no complete response in any group. Partial response was archieved in only 2 patients (7%) in Group C. No change was observed in 5 patients (24%) in Group B and 13 patients (46%) in Group B and 13 patients (46%) in Group C. Otherwise, the rest of them made progress. 2) The survival rates at the end of the third and sixth months were 64% and 16% in Group A, 76%; and 24% in Group B, and 100% and 86% in Group C, respectively. 3) The average survival times of patients were 4.7 months in Group A and 5.8 months in Group B, which were not significantly different from those of Group A, and 13.1 months in Group C (p=0.001). The results suggest that the combined modality of TAE with systemic FAM chemotherapy is an effective palliative treatment that prolongs survival of patients with large primary HCC.